|
ACADM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.593600E-04 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.854150E-02 |
| Stage1-vs-Stage3 |
2.043400E-01 |
| Stage1-vs-Stage4 |
1.588780E-04 |
| Stage2-vs-Stage3 |
2.235300E-03 |
| Stage2-vs-Stage4 |
1.049910E-04 |
| Stage3-vs-Stage4 |
1.017580E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.70950031908035E-10 |
| Normal-vs-Asian |
1.62470037423645E-12 |
| Caucasian-vs-AfricanAmerican |
8.503400E-01 |
| Caucasian-vs-Asian |
6.974000E-01 |
| AfricanAmerican-vs-Asian |
6.298400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.649000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.89392945770805E-12 |
| Normal-vs-Age(81-100Yrs) |
1.16689999996034E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.417400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.976000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.418600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.738200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.314400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.305800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.962300E-03 |
| Classical-VS-Follicular |
1.193690E-04 |
| Classical-VS-Other |
7.208000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
6.64699999486373E-08 |
| Tall-VS-Other |
3.841800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.457400E-01 |
| Follicular-VS-Normal |
2.84660000016146E-07 |
| Other-VS-Normal |
3.036500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.389200E-04 |
|
|
